Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Product Detail

Application


The SARS-CoV-2 Antigen Rapid Qualitative Test is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in human nasal swabs samples from individuals who are suspected of COVID-19. The test is intended as an aid in diagnosis of symptomatic individuals within the first 7 days of symptom onset.


Product Features


Fast Result
Easy-to-use
High specificity and sensitivity
Room temperature storage


Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
biotime PGI PGII Rapid Quantitative Test
PGI/PGII Rapid Quantitative Test
Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the myoglobin (Myo) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood, mainly used for auxiliary diagnosis of cardiac diseases.
HSV-2 IgG/IgM Rapid Test (Fluorescence Immunoassay)
HSV-2 IgG/IgM Rapid Test (Fluorescence Immunoassay)
The HSV-2 IgG/IgM Rapid Test is an in vitro immunoassay for the qualitative determination of IgG and IgM class antibodies to HSV2 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. The HSV-2 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses2 (HSV-2) infection -For in vitro diagnostic use only. For professional use only.
SARS-CoV-2 Antigen Rapid Test
SARS-CoV-2 Antigen Rapid Qualitative Test
The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Biotime HCY Rapid Quantitative Test
HCY Rapid Quantitative Test
Homocysteine, often shortened to HCY, is a thiol containing amino acid produced by the intracellular demethylation of methionine. Excess HCY in the bloodstream may cause injuries to arterial vessels due to its irritant nature and result in inflammation and plaque formation, which may eventually cause a blockage of blood flow to the heart.
Biotime FLI-600 FIA Immunoassay Analyzer
FLI-600 FIA Analyzer
FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact